Pyrexia, commonly known as fever, is a frequent clinical symptom encountered in practice, often indicative of underlying pathologies. Despite its ubiquity, its management can often be complex and multifaceted, necessitating a comprehensive understanding of its etiology, pathophysiology, and the latest treatment approaches.
Pyrexia results from an elevation in the body's set-point temperature, often triggered by pyrogens, substances typically produced in response to infection or inflammation. These pyrogens stimulate the hypothalamus, leading to the production of prostaglandins, which ultimately raise the body's temperature set-point.
A thorough clinical assessment is vital in managing pyrexia. It should include a detailed history, physical examination, and relevant investigations. The primary aim is to identify the source of infection or inflammation causing the fever. In some cases, pyrexia may be a symptom of non-infectious diseases such as malignancies or autoimmune disorders.
Treatment of pyrexia primarily involves addressing the underlying cause. Antipyretics can be used to provide symptomatic relief, but they do not treat the root cause. In cases of bacterial infection, antibiotics are the mainstay of treatment, while antivirals or antifungals may be required for viral or fungal infections, respectively. Non-pharmacological interventions, such as maintaining hydration and cooling measures, also play a key role.
In pediatric and geriatric populations, fever management requires particular attention due to differences in physiological responses and potential complications. Similarly, immunocompromised patients may present with atypical symptoms and have a higher risk of severe infections, necessitating a more cautious approach.
Managing pyrexia in clinical practice is a common but challenging task, requiring a thorough understanding of its causes, clinical assessment, and treatment strategies. By staying up-to-date with the latest research and guidelines, healthcare professionals can ensure effective management of pyrexia, ultimately improving patient outcomes.
1.
For MDS-Related Anemia, Telomerase Inhibitor Approved.
2.
Efficacy and safety of intravenous chemotherapy in children with intraocular retinoblastoma
3.
Admissions, medical schools, costs, and eligibility requirements information for FNB Onco-Anesthesia.
4.
Treating Depression: Crucial for Recovery From Fibromyalgia
5.
In postmenopausal women with hormone receptor-positive tumors, obesity increases the risk of breast cancer recurrence.
1.
Empowering Oncology with Data: Cloud Security, Real-World Evidence, and Clinical Insights
2.
Immune Regulation of Blood Cell Development
3.
Exploring the Effects of Radiation Therapy on Cystitis: A Journey to Better Health
4.
Transformative Frameworks in Oncology for Better Care
5.
Liposomal Doxorubicin and Mitomycin in Modern Cancer Treatment
1.
International Conference on Oncology, Cancer Prevention and Public Health
2.
International Conference on Cancer Nursing and Rehabilitation Strategies
3.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
4.
International Conference on Innovations in Critical Care for Oncology and Cardiology
5.
International Symposium on Oncology, Cardiology and Critical Care Innovations
1.
Targeting Oncologic Drivers: A New Approach to Lung Cancer Treatment
2.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
3.
Understanding the causes of anemia in adults beyond nutritional deficiencies
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part III
5.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation